Search Results 31-40 of 13272 for Acute severe asthma
... asthma exacerbations in adult subjects with inadequately controlled, severe asthma. Participation eligibility. Participant eligibility includes age, gender ...
The purpose of this study is to evaluate the effectiveness and safety of mepolizumab adjunctive therapy in participants with severe eosinophilic asthma by ...
Guidelines recommend that biologics be prescribed to people with severe asthma who have poor control of their asthma when using the standard treatment of ...
Asthma attack, acute or; Bronchospasm (difficulty with breathing), acute or; COPD flare-up or; Milk protein allergy, severe—Should not be used in patients with ...
... severe asthma. The study will evaluate the incidence of asthma exacerabtiona, other pharmacodynamic (PD) parameters such as lung function and asthma contorl ...
Serious or life-threatening breathing difficulties, particularly among people with poorly managed asthma. Lower quality of life because of not being able to ...
The purpose of this study is to evaluate several interventions given to participants with severe asthma. Interventions are administered in a crossover ...
... Asthma/asthmatic ... Diagnosis of asthma or recurrent severe asthmatic wheeze that is not controlled with chronic ... Active chronic or acute infection requiring ...
Short-acting beta agonists such as albuterol · Ipratropium (Atrovent) · Oral and intravenous corticosteroids (for serious asthma attacks).
Asthma attack, acute or; Bronchospasm (difficulty with breathing), acute or; Milk protein allergy, severe—Should not be used in patients with these conditions.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.